Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview

Bromocriptine mesylate - Generic Drug Details

« Back to Dashboard

What are the generic sources for bromocriptine mesylate and what is the scope of patent protection?

Bromocriptine mesylate
is the generic ingredient in three branded drugs marketed by Lek Pharm, Mylan, Sandoz Inc, Paddock Llc, Us Pharms Holdings I, Veroscience, and Zydus Pharms Usa Inc, and is included in eight NDAs. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Bromocriptine mesylate has nineteen patent family members in eleven countries.

There are nine drug master file entries for bromocriptine mesylate. Twelve suppliers are listed for this compound.

Summary for Generic Name: bromocriptine mesylate

Tradenames:3
Patents:10
Applicants:7
NDAs:8
Drug Master File Entries: see list9
Suppliers / Packagers: see list12
Bulk Api Vendors: see list36
Clinical Trials: see list184
Patent Applications: see list6,376
Therapeutic Class:Hormonal Agents, Suppressant (Pituitary)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:bromocriptine mesylate at DailyMed

Pharmacology for Ingredient: bromocriptine mesylate

Ingredient-typeErgolines
Drug ClassErgot Derivative
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
BROMOCRIPTINE MESYLATE
bromocriptine mesylate
TABLET;ORAL074631-001Jan 13, 1998ABRXNoNo► Subscribe► Subscribe
Us Pharms Holdings I
PARLODEL
bromocriptine mesylate
CAPSULE;ORAL017962-002Mar 1, 1982ABRXYesNo► Subscribe► Subscribe
Veroscience
CYCLOSET
bromocriptine mesylate
TABLET;ORAL020866-001May 5, 2009RXYesYes9,192,576► SubscribeY ► Subscribe
Mylan
BROMOCRIPTINE MESYLATE
bromocriptine mesylate
CAPSULE;ORAL077226-001Apr 4, 2005ABRXNoYes► Subscribe► Subscribe
Veroscience
CYCLOSET
bromocriptine mesylate
TABLET;ORAL020866-001May 5, 2009RXYesYes8,877,708► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot